Abstract
<p>(a) Quantitative analysis of PD-L1 mRNA and protein expression compared TP53 mutation with TP53 wild type tumor. (b) Quantitative analysis of PD-L1 mRNA and protein expression compared KRAS mutation with KRAS wild type tumor. (c) Immunohistochemistry (IHC) analysis of PD-L1 expression (strong: {greater than or equal to}50% vs. weak: 1-49% vs. negative: <1%) based on TP53 mutation status in a cohort of 93 lung adenocarcinoma. NS, no significant; mut, mutation; wt, wild type; *** P < 0.001, * P < 0.05</p>
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
